A game-changing drug to protect millions of brain cells from dying after a stroke has been developed in Australia with hopes it could save lives across the globe.
Argenica Therapeutics’ ARG-007 is a neuroprotective drug that aims to reduce brain tissue death after a stroke and extends the treatment window for patients, paving the way to prevent serious injury.